A whole‐genome scan for Artemisinin cytotoxicity reveals a novel therapy  for human brain tumors

A whole‐genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors

4.8
(345)
Write Review
More
$ 13.50
Add to Cart
In stock
Description

Glycerol-gradient fractionation of FPLC mono S column fractions

Publications

Anna LAEMMERER, Medical University of Vienna, Vienna

Preclinical Phenotyping

Anti-Cancer Effects of Artesunate in Human 3D Tumor Models of

Human/Mouse/Rat SOX2 Antibody (AF2018): 195+ Citations: R&D Systems

Christian STUDER, Novartis, Basel

Possible mechanisms of artemisinin peroxide bond opening. (A

Matheus Dyczynski - Chief Scientific Officer - Angal Biotechnology

SOX2 Antibody [Unconjugated] (AF2018): Novus Biologicals

SOX2 Antibody AF2018 from R&D Systems, a Bio-Techne Brand